𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A randomised controlled trial of interferon alfa 2A for the treatment of chronic hepatitis B virus infection: Factor, that influence response

✍ Scribed by Brook, MG; McDonald, JA; Karayiannis, P; Caruso, L; Forster, G; Harris, JRW; Thomas, HC

Book ID
122434032
Publisher
Elsevier Science
Year
1989
Tongue
English
Weight
47 KB
Volume
9
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A randomised controlled trial of recombi
A randomised controlled trial of recombinant interferon-Ξ³ in chinese patients with chronic hepatitis B virus infection
✍ Johnson Y. N. Lau; Dr. C. L. Lai; P. C. Wu; H. T. Chung; Anna S. F. Lok; H. J. L πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 433 KB

## Abstract Nineteen Chinese patients with chronic hepatitis B virus (HBV) infection, seropositive for HBV e antigen (HBeAg) and HBV DNA on at least three occasions in 6 months, were randomised to receive either recombinant human interferongamma (rlFNΞ³) 0.1 mg/m^2^ intramuscularly thrice weekly for

Treatment of hepatitis C virus–related c
Treatment of hepatitis C virus–related cirrhosis: A randomized, controlled trial of interferon alfa-2b versus no treatment
✍ Dominique-Charles Valla; Michele Chevallier; Patrick Marcellin; Jean-Louis Payen πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 97 KB πŸ‘ 1 views

To examine the effects of interferon (IFN) therapy on clinical, biochemical, and histological features in patients with compensated hepatitis C virus (HCV)-related cirrhosis, we have conducted a randomized, controlled trial of IFN therapy versus observation. Eight centers included a total of 99 pati